XML 17 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jul. 31, 2017
Apr. 30, 2017
Current Assets:    
Cash and cash equivalents $ 12,021 $ 12,506
Restricted cash 1,471 1,435
Receivables, less allowance: $193, $191, on each respective date 23,635 29,889
Inventories 17,001 14,935
Prepaid expenses and other current assets 1,556 1,047
Total Current Assets 55,684 59,812
Property, plant and equipment, at cost 51,998 51,568
Accumulated depreciation (38,222) (37,541)
Net Property, Plant and Equipment 13,776 14,027
Deferred income taxes 3,113 3,158
Other 3,991 3,919
Total Other Assets 7,104 7,077
Total Assets 76,564 80,916
Current Liabilities:    
Short-term borrowings and interest rate swaps 3,539 3,591
Current portion of long-term debt 1,105 918
Accounts payable 11,933 11,995
Employee compensation and amounts withheld 1,776 2,765
Deferred revenue 773 5,806
Other accrued expenses 2,487 1,852
Total Current Liabilities 21,613 26,927
Long-term debt 2,139 2,431
Accrued pension and deferred compensation costs 8,625 8,301
Total Liabilities 32,377 37,659
Commitments and Contingencies
Equity:    
Common Stock, $2.50 par value, Authorized - 5,000 shares; Issued - 2,716 shares; 2,715 shares; Outstanding - 2,713 shares; 2,712 shares, on each respective date 6,790 6,789
Additional paid-in-capital 2,755 2,695
Retained earnings 40,513 39,771
Accumulated other comprehensive loss (6,236) (6,319)
Common stock in treasury, at cost, 3 shares, on each date (53) (53)
Total Kewaunee Scientific Corporation Stockholders' Equity 43,769 42,883
Noncontrolling interest 418 374
Total Equity 44,187 43,257
Total Liabilities and Equity $ 76,564 $ 80,916